Conferences - Results from #8840

Viewing 8841-8860 of 11775 articles

WCE 2017: The Impact of Forces Applied during Ureteral Access Sheath Deployment on Ureteral Injury in a Porcine Model

WCE 2017: Pre-Clinical Assessment of Peri-operative Complications and Effect on Wound and Tissue Healing of sEphB4-HSA Administration Prior to Surgical Intervention

ESMO 2017: Second-line treatment patterns and outcomes of metastatic bladder cancer patients in clinical practice

ESMO 2017: Outcomes of patients with metastatic urothelial carcinoma with exclusive bone metastases: Focus on a special patient population

WCE 2017: Automated and dynamic classification of bladder cancer using deep learning on real-time confocal laser endomicroscopy images

ESMO 2017: Identification of genomic features underlying response of muscle-invasive bladder cancer to neoadjuvant sorafenib, gemcitabine, and cisplatin in an open-label, single-arm, phase 2 study

WCE 2017: Kidney irreversible electroporation does not cause significant injury to adjacent ureter or bowel in a porcine model

WCE 2017: Experimental Study for a New Medical Adhesion-Prevention Agent after Laparoscopic Nephrectomy

WCE 2017: Should All UTUC Patients be Screened for Lynch Syndrome? A Single Center Analysis of the Role of Screening UTUC patients for Lynch Syndrome

ESMO 2017: Kidney Cancer Poster Discussion – Invited Discussant

WCE 2017: Use of the Selective Cholesterol Absorption Inhibitor, Ezetimibe, and Subsequent Risk for Urolithiasis

WCE 2017: Single Surgeon Experience with Revision of Ureteroenteric Anastomosis for Benign Strictures after Urinary Diversion

WCE 2017: Arbutin as a novel prevention and therapy for calcium oxalate nephrolithiasis

WCE 2017: Effect of Testosterone Impregnated Pellet Therapy on Lower Urinary Tract Symptoms

WCE 2017: Role of Chaperone Proteins in Obstructed Renal Pelvis

ESMO 2017: Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: A joint study of the EAU-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration

ESMO 2017: Avelumab treatment of metastatic urothelial carcinoma in the phase 1b JAVELIN Solid Tumor study: Updated analysis with ≥6 months of follow-up in all patients

ESMO 2017: Immunotherapy for Urothelial Cancer – Longer Follow-up and Subgroup Analyses: Invited Discussant

ESMO 2017: 14 years of progress in mCRPC – New avenues for immunotherapy and precision medicine: Invited Discussant

ESMO 2017: Prostate Cancer Poster Discussion: Invited Discussant

438
439
440
441
442
443
444
445
446
447